Nurx Pricing History and Trajectory: What You're Actually Paying Over Time

At a glance
- Launch year / 2015, San Francisco, CA
- Original consult fee / $15 flat (2015-2019)
- Current uninsured consult fee / $25 per visit (2024)
- Annual membership option / $20/year (introduced ~2020, later discontinued for some services)
- ACA-covered patients / $0 copay for FDA-approved contraceptives under HRSA guidelines
- BBB rating / B (as of mid-2025; complaint history available at bbb.org)
- LegitScript status / Certified telehealth provider (legitscript.com)
- Services offered / Birth control, HRT, PrEP, skincare, mental health
- Insurance accepted / Most major US insurers; Medicaid in select states
- Average drug cost (uninsured pill pack) / $15-$50/month depending on formulation
How Nurx Has Priced Its Services From 2015 to Today
Nurx began as a $15-per-consultation model designed to undercut traditional clinic visits for birth control. Over roughly a decade, fees have climbed modestly while the service menu has expanded substantially. Understanding that trajectory tells you whether the current $25 consultation fee represents fair value or quiet price creep.
The 2015-2019 Flat-Fee Era
When Nurx launched in California in 2015, its pitch was simple: pay $15, answer an online questionnaire, receive a prescription. No video call required for birth control in states that allowed asynchronous telehealth. The $15 fee covered clinician review of the questionnaire and prescription issuance.
During this period the company accepted major insurance plans, meaning insured patients paid only their pharmacy copay for the medication itself. Under the ACA's preventive-services mandate, the Health Resources and Services Administration (HRSA) requires insurers to cover all FDA-approved contraceptive methods with no cost sharing for women with reproductive capacity. FDA-approved contraceptive labeling and coverage guidance is catalogued at the FDA's contraceptive guidance page. Practically, insured Nurx users in 2015 to 2019 often paid $0 for pills, patches, or rings.
The $15 consult fee was charged even to insured patients because most plans did not reimburse asynchronous telehealth visits at that time. That gap between "covered drug" and "uncovered consult" became a persistent consumer friction point visible in early Better Business Bureau complaint filings.
The 2020 Membership Restructure
Around 2020 Nurx introduced an optional $20 annual membership that waived per-visit consultation fees for repeat prescriptions. New patients still paid a one-time $25 initiation fee. The membership made financial sense for patients refilling the same pill prescription year after year. It made less sense for someone seeking a one-time PrEP evaluation or a skincare consult.
This period also saw Nurx expand into HIV pre-exposure prophylaxis (PrEP). The CDC recommends PrEP for all adults at substantial risk of HIV acquisition, with tenofovir-emtricitabine (Truvada or generic) as a first-line agent. CDC PrEP guidelines are available at cdc.gov. Adding PrEP changed Nurx's cost profile because PrEP drugs carry high list prices ($2,000+/month brand, $30-$60/month generic), and Gilead's patient assistance program covers Truvada for uninsured patients who qualify. Nurx navigated that assistance program on behalf of patients, which added administrative overhead that the $20 membership model did not fully capture.
2022 to Present: Per-Service Pricing
By 2022 Nurx had shifted most services to per-visit or per-condition fees rather than a blanket membership. As of the company's published fee schedule in 2024:
- Birth control consultation: $25 for new patients, $0 for insured patients whose plan reimburses telehealth
- HRT (hormone replacement therapy): $75 initial consultation, $35 follow-up
- Skincare: $25 per consultation
- Mental health: $25 per consultation (medication management only, not therapy)
- PrEP: $25 consultation; drug assistance programs typically cover medication cost
Those figures are drawn from Nurx's own publicly posted pricing page and should be verified directly before booking, as fees change without announcement.
What the ACA Preventive-Care Mandate Actually Covers at Nurx
The ACA's Section 2713 requires non-grandfathered health plans to cover preventive services rated A or B by the US Preventive Services Task Force (USPSTF) without cost sharing. USPSTF's contraception recommendation is at uspreventiveservicestaskforce.org. Separately, HRSA guidelines require coverage of all FDA-approved contraceptive methods.
What "No Cost Sharing" Means in Practice
"No cost sharing" means $0 copay, $0 deductible application, and $0 coinsurance for the contraceptive method itself. The consultation fee is a separate line item. Whether that $25 Nurx consultation is covered depends entirely on whether your insurer reimburses asynchronous telehealth visits for preventive services.
Since the COVID-19 public health emergency (PHE) ended in May 2023, telehealth flexibilities that had temporarily expanded asynchronous coverage began reverting to pre-PHE rules. CMS guidance on post-PHE telehealth is at cms.gov. For Medicaid and many commercial plans, asynchronous store-and-forward encounters (the kind Nurx uses for birth control) may not meet the definition of a "covered visit," leaving the $25 fee entirely out of pocket even for insured patients.
HRT and Menopause Coverage: A Different Picture
HRT consultations sit in a grayer coverage zone. The USPSTF currently recommends against using combined estrogen-progestogen therapy for the prevention of chronic conditions in postmenopausal women, giving it a D rating. That recommendation is at uspreventiveservicestaskforce.org. A D rating means insurers are not required to cover HRT consultations as preventive care. Patients seeking HRT through Nurx for symptom management rather than disease prevention typically pay the $75 consultation fee plus drug costs out of pocket unless their plan has specific HRT benefits.
The Menopause Society (formerly NAMS) published a 2023 position statement affirming that hormone therapy is appropriate for healthy symptomatic women under age 60 or within 10 years of menopause onset. That statement is at menopause.org. The clinical endorsement does not translate to automatic insurance coverage, which creates a real cost burden for Nurx's HRT patient segment.
Nurx Drug Costs: Cash Pay vs. Insurance vs. Manufacturer Coupons
The consultation fee is often the smaller number. Drug costs vary by orders of magnitude depending on insurance status, the specific formulation prescribed, and coupon availability.
Common Birth Control Drug Costs
Generic combined oral contraceptives (ethinyl estradiol / norethindrone, ethinyl estradiol / levonorgestrel, etc.) cost $15 to $30 per 28-day pack at cash-pay pharmacies. FDA's Orange Book lists approved generics at accessdata.fda.gov. GoodRx and similar discount programs often bring that to $10 to $20. Brand-name pills like Yaz or Seasonique run $100 to $200 per pack without insurance.
Nurx ships medication through its own pharmacy partner network. Prices charged through Nurx's pharmacy may differ from your local pharmacy's cash price for the identical generic. Before accepting automatic shipment, compare Nurx's quoted drug price against GoodRx at your local pharmacy. The FDA's guidance on pharmacy purchasing is a useful reference point for understanding bioequivalence of generics. FDA guidance on generic drug bioequivalence is at fda.gov.
HRT Drug Costs
Estradiol patches (generic estradiol transdermal) run approximately $30 to $60 per month cash pay. Progesterone capsules (generic Prometrium) cost $20 to $50 per month. Combined, an uninsured patient on standard menopausal HRT through Nurx might pay $75 (initial consult) + $35/month (follow-up) + $50 to $110/month (drugs) = roughly $160 to $220 in month one, dropping to $85 to $145 per month thereafter. Those figures assume cash pay and generic formulations.
PrEP Drug Costs
Generic tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) costs approximately $30 to $60 per month at most US pharmacies. Brand Truvada lists at over $2,000 per month. Gilead's Advancing Access program provides brand Truvada at no cost for uninsured patients below certain income thresholds. Gilead's assistance program information links to program details; the underlying clinical trial data for TDF/FTC efficacy in PrEP is published at pubmed.ncbi.nlm.nih.gov with PMID 20505727. In the iPrEx trial (N=2,499), daily oral TDF/FTC reduced HIV acquisition by 44% overall and by 92% among participants with detectable drug levels. Nurx's $25 PrEP consult fee is thus a minor cost relative to the drug, making insurance and assistance-program navigation the more financially significant service Nurx provides.
Is Nurx Legit? Licensing, Accreditation, and Complaint Patterns
Regulatory and Licensing Status
Nurx operates as a telehealth platform in which licensed clinicians (physicians, nurse practitioners, physician assistants) hold state-specific licenses and prescribe within their scope of practice. The company itself holds a LegitScript certification, a third-party standard for online pharmacies and telehealth providers that verifies legal operation, valid licensing, and appropriate prescribing practices. LegitScript's certification database is searchable at legitscript.com.
Prescriptions are transmitted to NABP-accredited pharmacies. The National Association of Boards of Pharmacy's VIPPS-accredited pharmacy list is at nabp.pharmacy. State medical boards regulate the individual clinicians, not Nurx the platform. If a patient believes a Nurx clinician acted below the standard of care, the complaint goes to the relevant state medical board, not to Nurx directly.
BBB Complaint History
The Better Business Bureau profile for Nurx as of mid-2025 shows a B rating with a pattern of complaints in three categories: billing disputes (charges persisting after subscription cancellation), prescription delays or errors, and difficulty reaching customer service. The BBB profile is at bbb.org. None of the public complaint summaries allege clinically serious prescribing errors, but the billing friction is consistent and spans multiple years.
A common complaint pattern: patients report being charged the annual membership fee after attempting to cancel, or receiving medication shipments after requesting cancellation. These are billing and customer-service problems, not clinical safety problems. Distinguishing between the two matters when evaluating whether a telehealth platform is "legit."
FDA Warning Letters and State Board Actions
As of the research date for this article, Nurx has not received an FDA warning letter related to improper prescribing or pharmacy operations. The FDA's warning letter database is publicly searchable. FDA warning letters are indexed at fda.gov. The absence of an FDA warning letter does not mean no regulatory scrutiny has occurred at the state level, but no publicly available state board enforcement actions specifically name Nurx as a corporate entity in major enforcement proceedings as of this writing.
A Framework for Evaluating Nurx's Total Cost of Care
Comparing Nurx to a traditional OB/GYN visit or to a competing telehealth platform (e.g., Wisp, Hey Doctor, Planned Parenthood Direct) requires accounting for all cost components, not just the headline consultation fee.
The Three-Cost Accounting Model
Component 1: Consultation fee. Nurx charges $25 for most services. A traditional OB/GYN visit billed as a preventive well-woman exam costs $0 out-of-pocket for insured patients under the ACA but can run $150 to $300 cash pay. For an uninsured patient, Nurx's $25 is meaningfully cheaper than an in-person visit.
Component 2: Drug cost. This varies by formulation, insurance status, and pharmacy used. Nurx does not always offer the lowest drug price. Running a GoodRx comparison for the specific generic before accepting Nurx's quoted price takes two minutes and can save $10 to $30 per month.
Component 3: Ongoing management fees. HRT patients need lab work (estradiol levels, metabolic panel) that Nurx does not order in-house. Those labs at a commercial lab (LabCorp, Quest) cost $60 to $150 out of pocket. The Endocrine Society's clinical practice guidelines for menopause management recommend periodic monitoring of symptom control and safety. Endocrine Society guidelines are at endocrine.org. Nurx's $35 follow-up fee does not include lab costs, which is a meaningful gap in the total cost picture.
Pricing Trajectory: Where Nurx Is Headed
The trajectory from $15 (2015) to $25 (2024) represents a 67% increase in the base consultation fee over nine years, roughly in line with US healthcare inflation. CMS National Health Expenditure data tracking healthcare inflation is at cms.gov. The expansion into higher-fee services (HRT at $75 initial, mental health at $25) increases average revenue per user more than the per-visit fee increase alone suggests.
Telehealth platforms broadly have moved toward higher per-visit fees as the COVID-era subsidy and growth-at-all-costs VC model receded. Nurx raised $40 million in Series C funding in 2020 but has not disclosed subsequent funding rounds publicly. Fee increases in a maturing, self-sustaining telehealth company are expected. What would be a red flag is fee increases combined with deteriorating clinical quality metrics, and available evidence does not currently support that conclusion.
Nurx Complaints: A Categorized Look at Consumer Grievances
Consumer complaints about Nurx cluster into four categories based on BBB filings, Trustpilot reviews, and Reddit threads in r/birthcontrol and r/TryingForABaby (cited here as qualitative signal, not primary evidence).
Category 1: Billing and Cancellation Issues
This is the most common complaint type. Patients report recurring charges after cancellation, difficulty getting refunds, and confusion about what the membership fee covers. The $20 annual membership introduced around 2020 seems to have generated most of these complaints. Nurx's billing practices do not violate federal law on their face, but the pattern suggests opaque subscription terms.
Category 2: Prescription Delays
Nurx's asynchronous model means clinician review can take up to 24 to 48 hours. For patients running out of an active prescription, that delay is clinically significant. Missing combined oral contraceptive pills increases pregnancy risk: the WHO's Medical Eligibility Criteria for Contraceptive Use recommends specific catch-up protocols depending on how many pills are missed and pill type. WHO MEC is at who.int. Nurx does not currently offer same-day or urgent prescription renewal, which is a genuine service limitation.
Category 3: Insurance Billing Confusion
Patients report receiving unexpected bills months after service, often related to how Nurx submitted claims and whether the patient's plan covered asynchronous telehealth. This confusion is partly structural: the intersection of ACA preventive-care mandates, state telehealth parity laws, and individual plan terms creates genuine ambiguity. CMS guidance on telehealth billing and coverage is at cms.gov. Nurx could reduce these complaints with clearer pre-service cost estimates.
Category 4: Customer Service Responsiveness
Patients describe difficulty reaching a human, long email response times, and chat-bot-first support flows. This is common across telehealth platforms and does not indicate clinical unsafety. It does indicate that patients with urgent medication questions need a backup plan beyond the Nurx messaging interface.
Nurx vs. Competing Telehealth Platforms: Pricing Comparison
Nurx is not the only telehealth option for birth control and HRT. A brief price comparison puts its trajectory in context.
Wisp: $39 consultation for birth control; $79 for HRT. Drug costs billed separately through partner pharmacies.
Hey Doctor: $20 consultation; limited state availability.
Planned Parenthood Direct: $0 consultation for existing Planned Parenthood patients in some states; drug costs standard.
Hers: $25 consultation; $15/month subscription option for ongoing care.
Among these, Nurx's $25 birth control consultation is competitive. Its HRT pricing ($75 initial) is on the lower end of the specialist telehealth market, where some platforms charge $150 or more for an initial hormone consultation. ACOG's guidance on contraceptive counseling, a standard-of-care reference for what these consultations should include, is at acog.org.
The ACOG Practice Bulletin No. 206 on combined hormonal contraceptives notes that "clinicians should provide information about the full range of contraceptive methods, including their mechanisms of action, effectiveness, benefits, risks, and side effects." A $25 asynchronous questionnaire-based consultation compresses that counseling substantially. Whether the compression is acceptable depends on patient health literacy and whether the patient has an existing primary care relationship.
Practical Guidance for Nurx Patients
Before starting or continuing with Nurx, take these specific steps.
Verify your insurance coverage for asynchronous telehealth before your first visit. Call the member services number on your insurance card and ask specifically whether store-and-forward telehealth visits for contraceptive management are covered as preventive care. Get a reference number for that call.
Compare the Nurx-quoted drug price against GoodRx at your local preferred pharmacy before accepting auto-shipment. For common generics, local pharmacy prices with discount cards often match or beat Nurx's pharmacy partner pricing.
If you are seeking HRT, budget for lab costs that Nurx does not include. A baseline estradiol, FSH, and metabolic panel at a cash-pay lab typically costs $80 to $130 at LabCorp or Quest. The Endocrine Society recommends baseline labs before initiating hormone therapy. Endocrine Society clinical practice guidelines are at endocrine.org.
If you are seeking PrEP, ask Nurx explicitly about Gilead's Ready, Set, PrEP program and Advancing Access patient assistance before paying cash for Truvada. The Health Resources and Services Administration's Ready, Set, PrEP program is at hrsa.gov.
Document any cancellation requests in writing through Nurx's messaging portal, and take screenshots with timestamps. Given the billing complaint pattern, this two-minute step reduces the risk of disputed charges significantly. A patient who cancels via phone with no record has limited recourse if charges continue.
Frequently asked questions
›Is Nurx a legitimate and safe telehealth platform?
›What does Nurx charge for birth control in 2024?
›Has Nurx raised its prices over time?
›Does insurance cover Nurx consultations?
›What are the most common Nurx complaints?
›Is Nurx cheaper than Planned Parenthood for birth control?
›Does Nurx work with Medicaid?
›Can I get HRT through Nurx?
›How does Nurx's PrEP service work?
›What happens if my Nurx prescription is delayed and I miss pills?
›Does Nurx have a subscription or membership fee?
›Has Nurx received any FDA warning letters?
References
- U.S. Food and Drug Administration. Birth control: medicines to help you. FDA.gov. Accessed July 2025.
- Centers for Disease Control and Prevention. Pre-exposure prophylaxis (PrEP). CDC.gov. Updated 2021. Accessed July 2025.
- U.S. Preventive Services Task Force. Contraception: Preconception Counseling Recommendation. Published 2020. Accessed July 2025.
- U.S. Preventive Services Task Force. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: Recommendation. Published 2017. Accessed July 2025.
- The Menopause Society. 2023 Menopause Hormone Therapy Position Statement. Menopause.org. Published 2023. Accessed July 2025.
- Centers for Medicare and Medicaid Services. Medicare Telehealth Frequently Asked Questions. CMS.gov. Accessed July 2025.
- Grant RM, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N Engl J Med. 2010;363(27):2587-2599. PMID 20505727.
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Accessdata.fda.gov. Accessed July 2025.
- U.S. Food and Drug Administration. Generic Drug Facts. FDA.gov. Accessed July 2025.
- U.S. Food and Drug Administration. Warning Letters Database. FDA.gov. Accessed July 2025.
- World Health Organization. Medical Eligibility Criteria for Contraceptive Use. 5th ed. Geneva: WHO; 2015.
- Endocrine Society. Menopause Clinical Practice Guidelines. Endocrine.org. Published 2015. Accessed July 2025.
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 206: Use of Hormonal Contraception in Women with Coexisting Medical Conditions. Obstet Gynecol. 2019;133(2):e128-e150.
- Centers for Medicare and Medicaid Services. National Health Expenditure Data. CMS.gov. Accessed July 2025.
- LegitScript. Telehealth Certification Program. LegitScript.com. Accessed July 2025.
- National Association of Boards of Pharmacy. VIPPS-Accredited Pharmacies. NABP.pharmacy. Accessed July 2025.
- Better Business Bureau. Nurx Business Profile. BBB.org. Accessed July 2025.